AGO Ovar 28
Laufzeit: 01.01.2023 - 31.12.2032
imported
Kurzfassung
Niraparib versus Niraparib in Combination with Bevaciczimab in patients with carcboplatin-taxane based chemotherapiy in advanced ovarian cancer
Laufzeit: 01.01.2023 - 31.12.2032
Niraparib versus Niraparib in Combination with Bevaciczimab in patients with carcboplatin-taxane based chemotherapiy in advanced ovarian cancer